ZOFAST

Einführung - ZOFAST

This text is only available in German.


"An Open-Label, Randomized, Multicenter Study to Evaluate the Use of Zoledronic Acid in the Prevention of Cancer Treatment-Related Bone Loss in Postmenopausal Women with ER+ and/or PgR+ Breast Cancer Receiving Letrozole as Adjuvant Therapy "

 

Aktuelles - ZOFAST

This text is only available in German.


Status:

Die Zofast-Studie ist geschlossen (Follow-Up läuft).

Ca. 20 teilnehmende Zentren in Deutschland

Die Studienware Letrozol (Femara®) und Zoledronat (Zometa®) wird gestellt.

 

Design - ZOFAST

This text is only available in German.


Adjuvante Aromatasehemmertherapie unter Zoledronat sofort versus verzögertem Beginn

Stratifikation nach Adjuv. CT und T-score

Read more: Design - ZOFAST

 

Kontakt - ZOFAST

This text is only available in German.


This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Fax: 06102 / 7480-440

Read more: Kontakt - ZOFAST

 

Current - ZOFAST-Study Status

This text is only available in German.


Closed



 

 
←   ↑